Evidence map›Paper›PMID 21070896›Full record

ArticleAmerican journal of human genetics2010

Extending rare-variant testing strategies: analysis of noncoding sequence and imputed genotypes.

Matthew Zawistowski, Shyam Gopalakrishnan, Jun Ding, Yun Li, Sara Grimm, Sebastian Zöllner

Abstract read
In one paragraph

Article in American journal of human genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Insights into blood lipids from rare variant discovery.Current opinion in genetics & development · 2015
    Review
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthew ZawistowskiDepartment of Biostatistics, University of Michigan, Ann Arbor, 48109, USA.
Shyam Gopalakrishnan
Jun Ding
Yun Li
Sara Grimm
Sebastian Zöllner

Funding

Population genetics for large-scale sequencing studies of diverse populationsR01HG005855 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Noah Rosenberg, Paul A Scheet · 2010 to 2026
$5.8M
Computational Statistic Approaches to Gene-Environment InteractionR01HL090564 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZOELLNER, SEBASTIAN · 2007 to 2009
$1.1M
NHGRI NIH HHS R01 HG005855NHLBI NIH HHS R01 HL090564NHLBI NIH HHS R01 HL90564
6 · The paper itself

Abstract

Next Generation Sequencing Technology has revolutionized our ability to study the contribution of rare genetic variation to heritable traits. However, existing single-marker association tests are underpowered for detecting rare risk variants. A more powerful approach involves pooling methods that combine multiple rare variants from the same gene into a single test statistic. Proposed pooling methods can be limited because they generally assume high-quality genotypes derived from deep-coverage sequencing, which may not be available. In this paper, we consider an intuitive and computationally efficient pooling statistic, the cumulative minor-allele test (CMAT). We assess the performance of the CMAT and other pooling methods on datasets simulated with population genetic models to contain realistic levels of neutral variation. We consider study designs ranging from exon-only to whole-gene analyses that contain noncoding variants. For all study designs, the CMAT achieves power comparable to that of previously proposed methods. We then extend the CMAT to probabilistic genotypes and describe application to low-coverage sequencing and imputation data. We show that augmenting sequence data with imputed samples is a practical method for increasing the power of rare-variant studies. We also provide a method of controlling for confounding variables such as population stratification. Finally, we demonstrate that our method makes it possible to use external imputation templates to analyze rare variants imputed into existing GWAS datasets. As proof of principle, we performed a CMAT analysis of more than 8 million SNPs that we imputed into the GAIN psoriasis dataset by using haplotypes from the 1000 Genomes Project.

Indexed as

RNA, UntranslatedAllelesGene FrequencyGenetic Association StudiesGenetic VariationGenome-Wide Association StudyGenotypeHumansModels, GeneticRiskStatistics as TopicRNA, Untranslated

Identifiers

PMID21070896
PMCPMC2978957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.